IL2 and gastric cancer: Furthermore, another study noted that patients with gastric cancer stage III or IV exhibited elevated levels of IL-2, while there was no distinction in the serum levels of IL-2 between patients with gastric cancer stage I or II and healthy controls (16), which aligns with our findings in Table S7.